Search

Adolf D. Berhane

Examiner (ID: 2145, Phone: (571)272-2077 , Office: P/2838 )

Most Active Art Unit
2838
Art Unit(s)
2102, 2111, 2722, 2838, 2899
Total Applications
4100
Issued Applications
3647
Pending Applications
180
Abandoned Applications
306

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6031080 [patent_doc_number] => 20110081365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'COMPOUNDS AND COMPOSITIONS AS TLR ACTIVITY MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/921129 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 122852 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081365.pdf [firstpage_image] =>[orig_patent_app_number] => 12921129 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/921129
Compounds and compositions as TLR activity modulators Feb 26, 2009 Issued
Array ( [id] => 102873 [patent_doc_number] => 07723385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Aniline derivatives as selective androgen receptor modulators' [patent_app_type] => utility [patent_app_number] => 12/392687 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28914 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723385.pdf [firstpage_image] =>[orig_patent_app_number] => 12392687 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/392687
Aniline derivatives as selective androgen receptor modulators Feb 24, 2009 Issued
Array ( [id] => 5380359 [patent_doc_number] => 20090192198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME' [patent_app_type] => utility [patent_app_number] => 12/390318 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 45135 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192198.pdf [firstpage_image] =>[orig_patent_app_number] => 12390318 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/390318
INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME Feb 19, 2009 Abandoned
Array ( [id] => 6097674 [patent_doc_number] => 20110003797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/919049 [patent_app_country] => US [patent_app_date] => 2009-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14731 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003797.pdf [firstpage_image] =>[orig_patent_app_number] => 12919049 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/919049
Hexahydrocyclopentyl[F]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators Feb 15, 2009 Issued
Array ( [id] => 6343787 [patent_doc_number] => 20100330136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'USE OF CATIONIC SURFACTANTS FOR THE PROTECTION AGANST TOOTH EROSION' [patent_app_type] => utility [patent_app_number] => 12/812813 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3918 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330136.pdf [firstpage_image] =>[orig_patent_app_number] => 12812813 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/812813
USE OF CATIONIC SURFACTANTS FOR THE PROTECTION AGANST TOOTH EROSION Feb 10, 2009 Abandoned
Array ( [id] => 5534137 [patent_doc_number] => 20090233925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Hepatitis C Virus Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/368465 [patent_app_country] => US [patent_app_date] => 2009-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41402 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233925.pdf [firstpage_image] =>[orig_patent_app_number] => 12368465 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/368465
Hepatitis C virus inhibitors Feb 9, 2009 Issued
Array ( [id] => 8201234 [patent_doc_number] => 08188131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Compounds that enhance Atoh1 expression' [patent_app_type] => utility [patent_app_number] => 12/368173 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 212 [patent_no_of_words] => 34015 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188131.pdf [firstpage_image] =>[orig_patent_app_number] => 12368173 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/368173
Compounds that enhance Atoh1 expression Feb 8, 2009 Issued
Array ( [id] => 5480732 [patent_doc_number] => 20090203689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'ABCA-1 ELEVATING COMPOUNDS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/367062 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22464 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203689.pdf [firstpage_image] =>[orig_patent_app_number] => 12367062 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/367062
ABCA-1 ELEVATING COMPOUNDS AND METHODS Feb 5, 2009 Abandoned
Array ( [id] => 6097937 [patent_doc_number] => 20110003842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'MARKER FOR DETERMINATION OF SENSITIVITY TO ANTI-CANCER AGENT' [patent_app_type] => utility [patent_app_number] => 12/865725 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6167 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003842.pdf [firstpage_image] =>[orig_patent_app_number] => 12865725 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/865725
Marker for determination of sensitivity to anti-cancer agent Jan 29, 2009 Issued
Array ( [id] => 9983698 [patent_doc_number] => 09029411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Thiophenes and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/321871 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21285 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12321871 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/321871
Thiophenes and uses thereof Jan 25, 2009 Issued
Array ( [id] => 9227583 [patent_doc_number] => 08633251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use' [patent_app_type] => utility [patent_app_number] => 12/863881 [patent_app_country] => US [patent_app_date] => 2009-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 22287 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12863881 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/863881
Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use Jan 18, 2009 Issued
Array ( [id] => 6495113 [patent_doc_number] => 20100009986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'SUBSTITUTED HETEROARYL DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/373947 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 134523 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009986.pdf [firstpage_image] =>[orig_patent_app_number] => 12373947 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/373947
Substituted heteroaryl derivatives Jan 14, 2009 Issued
Array ( [id] => 9239271 [patent_doc_number] => 08604063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies' [patent_app_type] => utility [patent_app_number] => 12/811931 [patent_app_country] => US [patent_app_date] => 2009-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13442 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811931 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/811931
Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies Jan 11, 2009 Issued
Array ( [id] => 6449185 [patent_doc_number] => 20100280127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'INHIBITING NEUROTRANSMITTER REUPTAKE' [patent_app_type] => utility [patent_app_number] => 12/812337 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 27876 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280127.pdf [firstpage_image] =>[orig_patent_app_number] => 12812337 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/812337
Inhibiting neurotransmitter reuptake Jan 8, 2009 Issued
Array ( [id] => 5343282 [patent_doc_number] => 20090181932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'COMPOSITIONS CONTAINING O-SULFATE AND O-PHOSPHATE CONTAINING ARYL SULFONAMIDE DERIVATIVES USEFUL AS beta-AMYLOID INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/349850 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8868 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181932.pdf [firstpage_image] =>[orig_patent_app_number] => 12349850 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/349850
COMPOSITIONS CONTAINING O-SULFATE AND O-PHOSPHATE CONTAINING ARYL SULFONAMIDE DERIVATIVES USEFUL AS beta-AMYLOID INHIBITORS Jan 6, 2009 Abandoned
Array ( [id] => 6433867 [patent_doc_number] => 20100278828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/811867 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18314 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278828.pdf [firstpage_image] =>[orig_patent_app_number] => 12811867 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/811867
Combination of anti-CTLA4 antibody with tubulin modulating agents for the treatment of proliferative diseases Jan 6, 2009 Issued
Array ( [id] => 9850342 [patent_doc_number] => 08952071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-10 [patent_title] => '(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases' [patent_app_type] => utility [patent_app_number] => 12/811694 [patent_app_country] => US [patent_app_date] => 2009-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28078 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811694 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/811694
(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases Jan 5, 2009 Issued
Array ( [id] => 5316558 [patent_doc_number] => 20090281156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'ENHANCING PHOTOSTABILIZATION OF OXYMETAZOLINE' [patent_app_type] => utility [patent_app_number] => 12/339394 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5162 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281156.pdf [firstpage_image] =>[orig_patent_app_number] => 12339394 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/339394
ENHANCING PHOTOSTABILIZATION OF OXYMETAZOLINE Dec 18, 2008 Abandoned
Array ( [id] => 6544937 [patent_doc_number] => 20100016279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'BICYCLIC DERIVATIVES FOR USE IN THE TREATMENT OF ANDROGEN RECEPTOR ASSOCIATED CONDITIONS-155' [patent_app_type] => utility [patent_app_number] => 12/338405 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 156761 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016279.pdf [firstpage_image] =>[orig_patent_app_number] => 12338405 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/338405
Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155 Dec 17, 2008 Issued
Array ( [id] => 5502814 [patent_doc_number] => 20090163502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists' [patent_app_type] => utility [patent_app_number] => 12/317026 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38805 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163502.pdf [firstpage_image] =>[orig_patent_app_number] => 12317026 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/317026
Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists Dec 16, 2008 Issued
Menu